AR068373A1 - Derivados de n-fenilacetamida, inhibidores de la enzima soat-1, y composiciones farmaceuticas y cosmeticas que los contienen - Google Patents

Derivados de n-fenilacetamida, inhibidores de la enzima soat-1, y composiciones farmaceuticas y cosmeticas que los contienen

Info

Publication number
AR068373A1
AR068373A1 ARP080103869A ARP080103869A AR068373A1 AR 068373 A1 AR068373 A1 AR 068373A1 AR P080103869 A ARP080103869 A AR P080103869A AR P080103869 A ARP080103869 A AR P080103869A AR 068373 A1 AR068373 A1 AR 068373A1
Authority
AR
Argentina
Prior art keywords
group
pyridyl
phenyl
alkyl
chlorine
Prior art date
Application number
ARP080103869A
Other languages
English (en)
Inventor
Thibaud Portal
Laurence Dumais
Laurent Lamy
Jerome Aubert
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of AR068373A1 publication Critical patent/AR068373A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Reivindicacion 1: Compuestos de formula (1) en donde: Y representa C(O) o CH2, R1 representa un grupo alquilo C1-6, R2 representa un átomo de hidrogeno, cloro, fluor o bromo, o un grupo alquilo C1-6, R3 representa un átomo de hidrogeno, un grupo alquilo C1-6, o un grupo -WNR6R7 en donde W representa C(O), C(S) o CH2, R6 representa un átomo de hidrogeno o un grupo alquilo C1-6 y R7 representa un átomo de hidrogeno, un grupo cicloalquilo o un grupo fenilo, R4 y R'4 son idénticos y representan un grupo alquilo C1-6 o R4 y R'4 están unidos entre sí y forman, con el átomo de carbono al cual están unidos, un grupo cicloalquilo, R5 representa un grupo seleccionado entre: un grupo fenilo no substituido o un grupo fenilo substituido por uno a tres substituyentes idénticos o diferentes seleccionados entre los átomos fluor, cloro, yodo o bromo, y los grupos alquilo C1-6, hidroximetilo, mono-, di- o trifluorometilo, hidroxilo, fenilo, 2-piridilo, 3-piridilo o 4-piridilo, alcoxi C1-6 , fenoxi, benciloxi, mono-, di- o trifluorometoxi, un grupo alquilo C1-12, opcionalmente substituido por uno o más grupos hidroxilo, o átomos de fluor, cloro, yodo o bromo, un grupo cicloalquilo o un grupo -(CH2)m-cicloalquilo en donde m es igual a 1, 2 o 3, un grupo aralquilo -(CH2)n-Ar en donde n es igual a 1, 2 o 3 y Ar representa un grupo fenilo no substituido, naftilo no substituido, o un grupo fenilo substituido por uno o tres substituyentes idénticos o diferentes seleccionados entre los átomos fluor, cloro, yodo y bromo, y los grupos alquilo C1-6, hidroximetilo, mono-, di- o trifluorometilo, hidroxilo, fenilo, 2-piridilo, 3-piridilo o 4-piridil, alcoxi C1-6, fenoxi, benciloxi, mono-, di trifluorometoxi, así como también sus sales, solvatos o hidratos farmacéuticamente aceptables y sus conformeros o rotámeros.
ARP080103869A 2007-09-06 2008-09-05 Derivados de n-fenilacetamida, inhibidores de la enzima soat-1, y composiciones farmaceuticas y cosmeticas que los contienen AR068373A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0757394A FR2920774B1 (fr) 2007-09-06 2007-09-06 Nouveaux derives de n-phenul acatamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contentant
US96009707P 2007-09-14 2007-09-14

Publications (1)

Publication Number Publication Date
AR068373A1 true AR068373A1 (es) 2009-11-11

Family

ID=39363894

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP080103869A AR068373A1 (es) 2007-09-06 2008-09-05 Derivados de n-fenilacetamida, inhibidores de la enzima soat-1, y composiciones farmaceuticas y cosmeticas que los contienen

Country Status (9)

Country Link
US (1) US8044082B2 (es)
EP (1) EP2197850B1 (es)
JP (1) JP2010538045A (es)
AR (1) AR068373A1 (es)
BR (1) BRPI0815455C1 (es)
CA (1) CA2698299A1 (es)
ES (1) ES2424659T3 (es)
FR (1) FR2920774B1 (es)
WO (1) WO2009030747A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2946341B1 (fr) * 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux derives de n-phenyl acetamide, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946346B1 (fr) * 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946345B1 (fr) * 2009-06-05 2011-05-20 Galderma Res & Dev Nouveaux derives dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946340B1 (fr) * 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux n-phenyl acetamie, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
FR2946342B1 (fr) * 2009-06-05 2011-06-24 Galderma Res & Dev Nouveaux derives de dioxo-imidazolidine, inhibiteurs de l'enzyme soat-1, compositions pharmaceutiques et cosmetiques les contenant.
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
CN104902892A (zh) * 2012-02-02 2015-09-09 悉尼大学 泪液膜稳定性的改进

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08151364A (ja) * 1994-02-18 1996-06-11 Nissan Chem Ind Ltd 含窒素環状化合物および除草剤
EP0987254B1 (en) * 1997-05-26 2004-12-22 Kowa Co., Ltd. Novel cyclic diamine compounds and medicine containing the same
WO2003018564A1 (fr) * 2001-08-22 2003-03-06 Kowa Company, Ltd Inhibiteur d'acat selectif de la paroi vasculaire
JP4333939B2 (ja) 2001-08-27 2009-09-16 ロード・コーポレーション トロリ線の吊架装置
RU2006134614A (ru) * 2004-03-02 2008-04-10 Такеда Фармасьютикал Компани Лимитед (Jp) Производное кумарина и его применение
US7409865B2 (en) * 2005-09-30 2008-08-12 General Electric Company Diaphragm structure
AR057579A1 (es) * 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
JP2007176809A (ja) * 2005-12-27 2007-07-12 Hideaki Natsukari 複素環置換アミド化合物、その製造法および医薬組成物
KR100662615B1 (ko) * 2006-01-13 2007-01-02 삼성전자주식회사 신호 변환 장치, 이를 구비한 ｒｆｉｄ 태그 및 ｒｆｉｄ태그의 구동 방법
US7612212B2 (en) * 2006-02-22 2009-11-03 Hoffmann-La Roche Inc. Substituted hydantoins
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms

Also Published As

Publication number Publication date
BRPI0815455C1 (pt) 2021-05-25
BRPI0815455A2 (pt) 2017-06-27
BRPI0815455A8 (pt) 2018-02-06
ES2424659T3 (es) 2013-10-07
EP2197850A1 (en) 2010-06-23
EP2197850B1 (en) 2013-06-26
WO2009030747A1 (en) 2009-03-12
BRPI0815455B1 (pt) 2020-11-10
US20100247583A1 (en) 2010-09-30
FR2920774A1 (fr) 2009-03-13
FR2920774B1 (fr) 2009-10-30
BRPI0815455B8 (pt) 2020-12-01
CA2698299A1 (en) 2009-03-12
US8044082B2 (en) 2011-10-25
JP2010538045A (ja) 2010-12-09

Similar Documents

Publication Publication Date Title
AR068373A1 (es) Derivados de n-fenilacetamida, inhibidores de la enzima soat-1, y composiciones farmaceuticas y cosmeticas que los contienen
AR061739A1 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
EA201170096A1 (ru) Замещенные производные пиримидона
CL2012000999A1 (es) Compuestos derivados de pirazoloespirocetona sustituida, inhibidores de acetil-coa carboxilasa; composicion farmaceutica que los comprende; uso para tratar o retrasar la progresion o el inicio de diabetes tipo 2, higado graso no alcoholico (hgna) o la resistencia hepatica a la insulina.
AR053554A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
AR067646A1 (es) Ariloxazoles sustituidos y su uso
AR069796A1 (es) Derivados de bencimidazol, sustituido por carboxilo o por hidroxilo, proceso para prepararlos y composiciones farmaceuticas que los contienen
ECSP066414A (es) Derivados de malonamida que bloquean la actividad de gama-secretasa
AR072962A1 (es) Derivados de pirimidin-4-ona sustituidos
AR084768A1 (es) Moduladores de la senda de complemento y usos de los mismos
AR058701A1 (es) Derivados de piracinil-s-espiro-oxacinoquinolin-pirimidin-triona como agentes antibacterianos
AR051326A1 (es) Pirazolobenzodiazepinas disustituidas
AR063988A1 (es) Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
EA200901379A1 (ru) Производные никотиновой кислоты как модуляторы метаботропных глутаматных рецепторов 5 подтипа
AR044829A1 (es) Derivados de bis-4-cloro fenil pirazinas
PE20170946A1 (es) 2-amino-6-(difluorometil)- 5,5-difluoro-6-fenil-3,4,5,6-tetrahidropiridinas como inhibidores de bace1
DOP2006000045A (es) Derivados del (1,5-difenil-1h-pirazol-3-il oxadiazol, su preparacion y su aplicacion en terapeutica
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
CY1114354T1 (el) Νεα παραγωγα βενζαμιδιου ως ανταγωνιστες βραδυκινινης
MY169179A (en) Novel piperidine compound or salt thereof
AR056574A1 (es) Derivados de pirazol, composiciones que contienen dichos compuestos y procedimientos de uso
CO4910169A1 (es) Pirazoles como inhibidores de la fosfolipasa secretoria no pancreatica a2 humana
AR070263A1 (es) Derivados de oxazepinopirimidinona arilamido sustituidos, utiles en el tratamiento y/o prevencion de enfermedades neurodegenerativas y otras, medicamentos que los contienen y proceso de preparacion e intermediarios.
AR074053A1 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), y composiciones farmaceuticas que los contienen
AR068372A1 (es) Derivados de n-fenilacetamida, inhibidores de la enzima soat1, y composiciones farmaceuticas y cosmeticas que los contienen

Legal Events

Date Code Title Description
FB Suspension of granting procedure